Short answer:
Leucovorin (folinic acid) is a generic drug, so there isn’t a single “owner.” The active ingredient is sold by many manufacturers worldwide, and the brand name “Leucovorin” is owned by a few companies that market specific formulations (usually as a prescription drug or over‑the‑counter supplement).
---
1. The generic picture
| Region | Common generic manufacturers | Notes |
|--------|-----------------------------|-------|
| United States | Sandoz (Novartis), Pfizer, Teva, Mylan (now Viatris), and several smaller generic companies | Available as oral tablets, oral suspension, and injectable solution. |
| Europe | Sandoz, Pfizer, Novartis, Teva, and other EU‑based generics | “Leucovorin” is a brand name used by some manufacturers (e.g., Bayer in Germany). |
| Asia | Sandoz, Teva, Sun Pharmaceutical, and local generic producers (India, China) | Often sold in capsule or tablet form. |
| Australia/New Zealand | Sandoz, Pfizer, and local generics | Available by prescription. |
Because the compound is no longer under patent, many companies can produce and sell it.
---
2. Trademark / brand ownership
The brand name “Leucovorin” is protected by trademark in many countries. A few companies that own or license the trademark for specific products include:
| Company | Typical formulation | Typical market |
|---------|--------------------|----------------|
| Pfizer | Oral tablets, oral solution | U.S. (often under the brand “Leucovorin”) |
| Sandoz (Novartis) | Oral tablets, injectable | Europe, U.S. (brand “Leucovorin” in some markets) |
| Bayer | Oral tablets | Germany, some EU countries |
| Teva | Oral tablets, oral suspension | U.S. & global generic market |
| Other local manufacturers | Various | Local markets (e.g., “Leucovorin” brand in India or China) |
The trademark can change hands through licensing or acquisition, so the current owner may vary by country and by product line.
---
3. Why it matters
- Generic use: If you’re looking for the drug for therapy (e.g., to “rescue” a patient from methotrexate toxicity), the generic versions are interchangeable and usually less expensive.
- Brand differences: Some branded versions include specific excipients, dosage strengths, or delivery devices that may be relevant to prescribing practices.
- Regulatory status: The active ingredient is FDA‑approved (and approved by other regulatory bodies) as a generic. Any branded version must still meet the same quality and safety standards.
---
4. Bottom line
- Leucovorin itself is not owned by any single entity; it’s a generic drug sold by many manufacturers.
- The name “Leucovorin” is a trademark held by specific companies that market particular formulations. In the U.S., Pfizer and Sandoz (Novartis) are two of the most prominent holders.
- For most clinical use, the generic drug will suffice and is typically the most cost‑effective option.
If you need the exact manufacturer for a specific batch or formulation (for example, for a pharmacy order or a regulatory inquiry), it’s best to check the packaging or the prescribing information, which will list the company name and country of origin.